Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
Clinical trial NCT02574637 · TERMINATED
Trial details
- NCT number
- NCT02574637
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-05
- Primary completion
- 2017-07-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.